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ABSTRACT: The handling of low, middle and high molecular weight markers was examined 
in seven stable dialysis patients during hemofiltration with different membranes. Four 
membranes were examined in a randomized, crossover order (polysulfone, poly amide, AN69 
polyacrylonitrile, Asahi polyacrylonitrile) by measuring plasma and dialysate concentrations 
of phosphate, creatinine, vitamin B12, t52-microglobulin, furanic acid, hippuric acid, retinoi-
binding protein, alpha-1 -antitrypsin, and albumin. Sieving coefficients and plasma clearances 
of (32-microglobulin or retinoi-binding protein were markedly or slightly lower during 
hemofiltration with the Asahi polyacrylonitrile membrane than with the other membranes 
(highest removal with polysulfone/AN69 polyacrylonitrile membranes). No differences of 
obvious clinical relevance could be seen between the four membranes. A high /32-
microglobulin removal rate might be important to prevent dialysis-associated amyloidosis, 
(int J Artif Organs 1992; 15: 408-12) 
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INTRODUCTION 
C o n t r o v e r s i e s regard ing the role of u rem ic tox ins , 
e.g. m idd le m o l e c u l e s , in morb id i t y and morta l i ty of 
pat ients wi th end -s tage renal d i sease ( E S R D ) stil l 
pers ist (1, 2), but have s t imu la ted the deve lopmen t of 
membranes that remove these midd le mo lecu les . S i n c e 
the ident i f ica t ion of ^ - m i c r o g l o b u l i n as the major 
c o m p o n e n t in d i a l y s i s -assoc i a ted a m y l o i d o s i s (3, 4), 
the remova l of th is prote in du r ing hemod ia l ys i s , he -
mof i l t ra t ion and per i tonea l d ia l ys is has been w ide ly 
s tud ied (5-12). 
/ ^ - m i c r o g l o b u l i n is removed better du r i ng h e m o d i -
a lys is wi th syn the t i c m e m b r a n e s (e.g. A N 6 9 p o l y a c r y l -
oni t r i le , po l ysu l fone ) , than with ce i l u l os i c m e m b r a n e s 
(12-14, 27, 28). 
T h e present s tudy c o m p a r e d charac te r i s t i cs of four 
di f ferent m e m b r a n e s in vivo wi th regard to parameters 
that serve to ca l cu la te c l e a r a n c e s and e l im ina t ion of 
markers main ly dependen t on the s ize of the molecu le 
(e.g. phospha te , c rea t in ine , a lpha-1 -an t i t r yps in , a l -
bumin) and of markers more dependen t on the 
protein b ind ing and /o r of potent ial in f luence as uremic 
tox ins (e.g. ^ - m i c r o g l o b u l i n , 3 - ca rboxy -4 -me thy l -5 -
p r o p y l - 2 - f u r a n p r o p i o n i c ac id = fu ran ic a c i d , h ippur ic 
ac i d , v i tamin B 1 2 , re t i no i -b ind ing prote in) . 
PATIENTS AND METHODS 
S e v e n s tab le pat ients wi th E S R D were s tud ied after 
g iv ing their i n fo rmed consen t . The i r mean age was 54 
± 11 years (36-70) a n d they had been on chron ic 
h e m o d i a l y s i s t reatment for 51 ± 57 mon ths (7-144); 
the e t io logy of the renal fa i lure was d iabe tes mell i tus 
(n=2), c r e s c e n t i c g lomeru loneph r i t i s (n-1) , m e s a n g i c 
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prol i ferat ive g lomeru lonephr i t i s (n=1), interstit ial n e p h -
ritis (n=1), c h r o n i c g lomeru lonephr i t i s (n=1), u n k n o w n 
(n=1). Pos t -d i l u t i on hemof i l t ra t ion (3 h dura t ion ; 18 L 
of subst i tu t ion f lu id ; 250 m l /m in b l ood f low; 300 mm 
Hg t r a n s m e m b r a n e pressure ; A F G 04 mach ine , D ia ly -
seTechnik , Rhe ins te t ten-Forchhe im, Germany) was per-
formed us ing four di f ferent m e m b r a n e s [F i l t ra l R 16 
(Hospa l Med i z i n techn i k G m B H , N u r n b e r g , G e r m a n y , 
A N 6 9 po lyacry lon i t r i l e m e m b r a n e , 1.7 m 2 sur face) , H F 
8 0 R ( F r e s e n i u s A G , B a d H o m b u r g , G e r m a n y , p o l y s u l -
fone m e m b r a n e , 1.8 m 2 sur face) , F H 8 8 R ( G a m b r o 
A B , L u n d , S w e d e n , po l yam ide membrane , 2.0 m 2 
surface) P A N 250 N O V A R (D iamed Med i z i n techn i k 
G m b H , K o l n , G e r m a n y , A s a h i po lyacry lon i t r i l e m e m -
brane, 1.8 m 2)] in a r a n d o m i z e d order in all pat ients. 
Three hemof i l t ra t ion p r o c e d u r e s were d o n e with e a c h 
membrane (six pat ients c o u l d be s tud ied a lmost 
comple te ly wi th all m e m b r a n e s , whereas one pat ient 
was s tud ied incomp le te ly ) . 
B l o o d s a m p l e s f rom the arterial and venous l ines 
and s a m p l e s of f i l trate were ob ta ined 15 min , 1h, 2h , 
and 3h after the start of the hemof i l t ra t ion p rocedu re . 
H ippur i c ac id and fu ran ic ac id were measu red by 
H P L C (15), v i tamin B 1 2 by a rad io recep to r test (Fa. 
B ie rmann , B a d N a u h e i m , G e r m a n y ) mod i f i ed to reach 
a de tec t ion l imit of 10 p g / m l , and a l bum in , a l p h a - 1 -
ant i t rypsin, and re t ino i -b ind ing prote in by n e p h e l o -
metry (Beh r i ng -Nephe lome te r -Ana l yze r , Beh r i ngwerke , 
Warburg, G e r m a n y ) us ing ant isera f rom B e h r i n g and 
Mod i f i ca t ions in the assay sys tems in o rder to reach 
detect ion l imits of 0.2 m g / d l , 0.5 m g / d l , and 0.12 m g / 
dl. respect ive ly , ^ - m i c r o g l o b u l i n was measu red by a 
commerc ia l l y ava i lab le E l i sa ( S y n e l i s a B E T A - 2 - M I K R O -
G L O B U L I N R E l ias Med i z i n techn i k G m b H , F re ibu rg , 
Germany) wi th a de tec t ion l imit of 0.05 m g / d l . C r e a t i -
v e and phospha te were measu red by rout ine labo-
r a t o r y me thods . 
Stat is t ica l ana lys i s was d o n e by S tuden t ' s t-test and 
P va lues < 0.05 were c o n s i d e r e d stat is t ica l ly s ign i f i -
C a n t ; da ta are g iven as mean ± S D . 
The s iev ing coeff ic ient of a marker was ca lcu la ted as 
s ' ev ing coef f i c ien t 
2 x C f i l trate 
c a r t e r i a l + c v e n o u s 
w h e r e C s tands for concen t ra t i on of the marker in 
e ' t he r the fi l trate or arter ial or v e n o u s p l asma . 
T h e p l asma c l ea rance of a marker was ca l cu la ted 
as s iev ing coef f ic ient x ul traf i l t rat ion rate. If the 
concen t ra t i on of a marker in the fi l trate was be low 
the detect ion limit of the assay, the lowest measurab le 
concen t ra t i on was used for ca l cu la t i on of the s iev ing 
coef f i c ien t and consecu t i ve l y of the p l asma c l ea rance . 
T h e s e s iev ing coef f i c ien ts and p l a s m a c l e a r a n c e s are 
the m a x i m u m poss ib le va lues and thus might c a u s e 
s o m e overes t imat ion . 
RESULTS 
M e a n s iev ing coef f i c ien ts of phospha te , c rea t in ine , 
^ - m i c r o g l o b u l i n , h ippur i c ac i d , and re t ino i -b ind ing 
prote in are g iven in Tab le I. T h e ^ - m i c r o g l o b u l i n 
s iev ing coef f ic ient was s ign i f i can t ly lower (p < 0.001) 
du r ing hemof i l t ra t ion wi th the A s a h i po lyac ry lon i t r i l e 
m e m b r a n e than with the other m e m b r a n e s and was 
h ighest wi th the A N 6 9 and po lysu l fone membranes . A 
s im i la r pattern was f ound for re t ino i -b ind ing pro te in , 
removal be ing highest with the po lysu l fone membrane . 
D i f fe rences between m e m b r a n e s were on ly s l ight for 
c rea t in ine and h ippur i c ac i d . S iev ing coef f i c ien ts were 
< 0.02 for v i tamin B 1 2 and fu ran ic ac i d , < 0.004 for 
a lpha-1-an t i t r yps in , and < 0.001 for a l bum in . 
P l a s m a c l e a r a n c e s of phospha te , c reat in ine, (52-
m i c r o g l o b u l i n , h ippur i c a c i d , and re t ino i -b ind ing p ro -
tein are g iven in T a b l e II. P l a s m a c l e a r a n c e s of /3 2 -
m i c rog lobu l i n and re t ino i -b ind ing prote in were s ign i f i -
cant ly lower with the A s a h i po lyacry loni t r i le membrane 
than with the other membranes . P l a s m a c l ea rances 
for the A N 6 9 m e m b r a n e tended to be lower for the 
rema in ing markers . P l a s m a c l e a r a n c e s were < 1.5 m l / 
min for v i tamin B 1 2 , < 1.0 m l /m in for a lpha-1-an t i t r yp -
s in and fu ran ic ac i d , and < 0.2 m l /m in for a l bum in . 
DISCUSSION 
Synthe t i c h igh- f lux m e m b r a n e s used in a convec t i ve 
m o d e were s tud ied wi th regard to marker s u b s t a n c e s 
wi th mo lecu la r masses rang ing f rom 98 to 66500 
Da l tons . A l l s tud ies were done in vivo b e c a u s e of the 
w e l l - k n o w n effect of s e c o n d a r y m e m b r a n e fo rmat ion , 
due to con tac t of the m e m b r a n e with b l ood , wi th the 
subsequen t dec rease of s iev ing coef f i c ien ts not d e -
tec tab le in vitro (16). 
In vivo clearances of different hemoiliters 
TABLE I- M E A N S I E V I N G C O E F F I C I E N T S ( ± S D ) D U R I N G H E M O F I L T R A T I O N W I T H F O U R D I F F E R E N T 
M E M B R A N E S 
AN69 Asahi 
polyacrylonitrile polysulfone polyamide 
n-72 n=60 n-64 n=67 
phosphate 0.77 + 0.20 0.77 + 0.15 0.78 + 0.19 0.79 ±0 .18 
creatinine 1.03 ± 0.22 1.07 + 0.26 1.07 + 0.14 1.09 ±0 .20* 
hippuric acid 0.54 ±0 .10 0.61 ±0 .16** 0.58 ±0 .14* 0.57 ± 0.08*+ 
^ -m ic rog lobu l in 0.50 + 0.18 0.08 ± 0.09*** 0.54 + 0.17 + ~ 0.35 + 0.20W* 
### 
retinol-binding protein 0.02 ± 0.02 0.01 ± 0.00 0.06 + 0.07 vs* 0.03 ± 0.02v; 
### 
*: in comparison with AN69 membrane; in comparison with Asahi membrane, #: in comparison with polysulfone membrane 
p < 0.05, 1 symbol; p < 0.01, 2 symbols; p < 0.001, 3 symbols. 
TABLE II - P L A S M A C L E A R A N C E (ml /min) O F D I F F E R E N T M A R K E R S D U R I N G H E M O F I L T R A T I O N WITH 








15 min 74 82 82 86 
1 h 69 77 80 78 
phosphate 2 h 70 72 74 71 
3 h 52 60 69 73 
mean 66 ± 2 3 73 + 20* 76 ± 2 4 * * 77 ± 22** 
15 min 100 109 112 117 
1 h 93 103 109 107 
creatinine 2 h 94 93 102 98 
3 h 71 96 90 92 
mean 90 + 30 101 + 30* 105 ± 25** 105 ± 2 3 * * 
15 min 54 67 59 66 
1 h 50 63 58 59 
hippuric acid 2 h 47 57 56 52 
3 h 37 48 51 45 
mean 47 ± 15 59 ± 22*** 56 ± 16*** 5 6 + 15*** 
15 min 34 7 63 27 
1 h 49 9 60 31 
^ -m ic rog lobu l in 2 h 55 8 52 36 
3 h 37 7 41 39 
mean 44 ± 2 0 8 ± 8 * * * 54 ± 22 +*v 33 ± 21 ;v* 
### 
15 min 3 1 11 3 
1 h 2 1 4 3 
retinol-binding protein 2 h 2 1 4 3 
3 h 1 1 3 2 
mean 2 + 2 1 + 1*** 6 ± 8 ;v . 2 ± 3 iV 
*. in comparison with AN69 membrane; *: in comparison with Asahi membrane, #: in comparison with polysulfone membrane 
p < 0.05, 1 symbol; p < 0.01, 2 symbols; p < 0.001, 3 symbols. 
Siev ing coef f i c ien ts and p l a s m a c l e a r a n c e s of low 
mo lecu la r mass markers (98-240 Dal tons) d o not 
marked ly dif fer wi th the var ious m e m b r a n e s , p rov ided 
that the m o l e c u l e s are suf f ic ient ly so lub le as free 
subs tances in p l asma . T h i s is demons t ra ted by the 
high va lues for phospha te and creat in ine, no note-
worthy remova l of fu ran ic ac id due to > 99% prote in 
b ind ing and an in termedia te response of h ippu r i c 
ac id part ly d u e to the 40 -50% prote in b ind ing (Tabs. I 
and II). 
T h e remova l of low mo lecu la r markers s e e m e d to 
be s o m e w h a t lower wi th the A N 6 9 m e m b r a n e . P h o s -
phate, c rea t in ine and h ippu r i c ac id p l a s m a c l e a r a n c e s 
dec reased by abou t 10-20% dur ing three hou rs of 
hemof i l t ra t ion wi th no o b v i o u s d i f fe rence be tween 
membranes . T h e s e resul ts are in a c c o r d a n c e wi th the 
' i terature, but most au thors e i ther invest igated on ly 
one or two m e m b r a n e s or a l imi ted n u m b e r of marke r 
subs tances (only c rea t in ine was i nc l uded in the m a -
jority of reports) (12, 17-19). T h e role of h ippu r i c ac id 
and fu ran ic a c i d as u remic tox ins has not yet been 
es tab l i shed , but marked ly e levated p l a s m a levels have 
been reported (15, 20, 21). S c h o o t s et al . (21) reported 
that h ippu r i c a c i d is an i ndependen t parameter that 
corre la tes c l o s e l y wi th res idua l renal func t ion . 
With the e x c e p t i o n of the marked ly lower remova l 
o f ^ - m i c r o g l o b u l i n and re t ino i -b ind ing prote in by the 
Po lyacry lon i t r i le A s a h i m e m b r a n e (and the better 
results wi th the po l ysu l f one a n d A N 6 9 membranes ) , 
t h e s iev ing coe f f i c ien ts and p l a s m a c l e a r a n c e s of 
middle mo lecu la r m a s s marke rs (1355-21000 Dal tons) 
were not di f ferent wi th the m e m b r a n e s tes ted. L o w 
removal rates of v i tamin B 1 2 and re t ino i -b ind ing p ro -
tein are due to prote in b i nd ing (e.g. t r a n s c o b a l a m i n , 
Prea lbumin) , and are in a c c o r d a n c e wi th p rev ious 
r epor ts (16, 22, 23). N o app rec iab le removal of v i tamin 
1^2 was seen desp i te its low mo lecu la r mass (1355 
da l tons) , and this makes v i tamin B 1 2 a usefu l marker 
0|% in vitro. S iev ing coe f f i c ien ts of ^ - m i c r o g l o b u l i n 
r a r i g e f rom abou t 0.4-0.8 (12, 16, 17, 19, 22-24) and 
t e n d to dec rease modera te l y to marked ly (16, 22, 23) 
0 r remain cons tan t du r ing hemof i l t ra t ion (24). Inter-
est ingly, A s a h i po lyacry lon i t r i l e ( P A N ser ies) s e e m s 
t o be a lmos t i m p e r m e a b l e to ^ - m i c r o g l o b u l i n , in 
contrast to A N 6 9 po lyacry lon i t r i l e (16, 22, 26), w h i c h 
S e e m s to have a h igh init ial abso rp t i on of j 3 2 -m ic ro -
g lobu l i n (24, 25, 27, 28). A s repor ted e l sewhere the 
h igh mo lecu la r mass markers a l b u m i n a n d a l p h a - 1 -
ant i t ryps in were not r emoved in subs tan t ia l a m o u n t s 
in the present s tudy (16, 19, 22, 23); m ino r remova l of 
a lpha-1 -an t i t r yps in and a l b u m i n has been d e m o n -
strated du r i ng the very first few minu tes (23) be fore 
s e c o n d a r y m e m b r a n e s f o rmed , but in the present 
s tudy the first measu remen ts were m a d e after 15 
minutes . 
In c o n c l u s i o n , with the excep t i on of the very low 
remova l of ^ - m i c r o g l o b u l i n and to a m ino r extent of 
re t ino i -b ind ing prote in wi th the A s a h i po lyacry lon i t r i l e 
membrane , the other d i f ferences between the synthet ic 
m e m b r a n e s e x a m i n e d with regard to remova l of 
marker s u b s t a n c e s wi th mo lecu la r masses f rom about 
100 to abou t 67000 Da l tons s e e m to be of little 
c l i n i ca l re levance. 
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